Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cellular and Molecular Biology

Comment on: “Evolving roles of CD38 metabolism in solid tumour microenvironment”

British Journal of Cancer volume 128, page 491 (2023)Cite this article

Subjects

In their paper, Gao et al. discuss the widely accepted idea of the major role that CD38 ectonucleotidase plays in the tumour microenvironment [1]. They mention the regulation mechanisms of CD38 enzymatic activity with a specific reference to Zocchi et al. [2] to support their statement about ATP-mediated suppression of cADPR hydrolysis. However, the referenced manuscript does not contain any convincing evidence of CD38 hydrolase inhibition by ATP. Meanwhile, Takasawa et al. indeed have demonstrated that ATP inhibited the cADPR hydrolase activity which resulted in the accumulation of cADPR [3]. Further studies confirmed this observation and provided insights into the mechanism for competitive binding of ATP to the cADPR-binding site of CD38 [4] to put forward a model for a cADPR-mediated signalling system in pancreatic islet β-cells [5]. Based on this model, extensively reviewed in [6], ATP-binding leads to the accumulation of cADPR. Given all the above, ATP serves as a competitive inhibitor of cADPR hydrolysis and, while having no influence on CD38 cyclase activity, facilitates the accumulation of cADPR.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Data availability

Not applicable.

References

  1. Gao L, Du X, Li J, Xiao-Feng Qin F. Evolving roles of CD38 metabolism in solid tumour microenvironment. Br J Cancer. 2022. https://doi.org/10.1038/s41416-022-02052-6.

  2. Zocchi E, Franco L, Guida L, Calder L, De Flora A. Self-aggregation of purified and membrane-bound erythrocyte CD38 induces extensive decrease of its ADP-ribosyl cyclase activity. FEBS Lett. 1995;359:35–40.

    Article  CAS  PubMed  Google Scholar 

  3. Takasawa S, Tohgo A, Noguchi N, Koguma T, Nata K, Sugimoto T, et al. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem. 1993;268:26052–4.

    Article  CAS  PubMed  Google Scholar 

  4. Tohgo A, Munakata H, Takasawa S, Nata K, Akiyama T, Hayashi N, et al. Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase. J Biol Chem. 1997;272:3879–82.

    Article  CAS  PubMed  Google Scholar 

  5. Okamoto H, Takasawa S. Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in β-cells. Diabetes. 2002;51:S462–73.

    Article  CAS  PubMed  Google Scholar 

  6. Takasawa S. CD38–cyclic ADP-ribose signal system in physiology, biochemistry, and pathophysiology. Int J Mol Sci. 2022;23:4306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

    Pavel Nesmiyanov

Authors
  1. Pavel Nesmiyanov
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PN was the single author.

Corresponding author

Correspondence to Pavel Nesmiyanov.

Ethics declarations

Competing interests

The author declares no competing interests.

Ethics approval and consent to participate

Not applicable.

Consent to publish

Not applicable.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nesmiyanov, P. Comment on: “Evolving roles of CD38 metabolism in solid tumour microenvironment”. Br J Cancer 128, 491 (2023). https://doi.org/10.1038/s41416-022-02113-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-022-02113-w

Search

Advanced search

Quick links